...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Synthesis and cytotoxicity evaluation of glycosidic derivatives of lawsone against breast cancer cell lines
【24h】

Synthesis and cytotoxicity evaluation of glycosidic derivatives of lawsone against breast cancer cell lines

机译:对乳腺癌细胞系授权糖苷衍生物的合成和细胞毒性评价

获取原文
获取原文并翻译 | 示例
           

摘要

Breast cancer is the most incident and mortal cancer type in women, with an estimated 2 million new cases expected by 2020 worldwide, with 600,000 deaths. As not all breast cancer types respond to the anti-hormonal therapy, the development of new antineoplastic drugs is necessary. Lawsone (2-hydroxy-1,4-naphtoquinone) is a natural bioactive naphtoquinone displaying a range of activities, with dozens of derivatives described in the literature, including some glycosides possessing antitumor activity. Here, a series of glycosides of lawsone are reported for the first time and all compounds displayed good activity against the SKBR-3 cell line, with IC50 below 10 mu M. The most promising derivative was the glycosyl triazole derived from peracetylated D-glucose (11), which showed better cytotoxicity against SKBR-3 (IC50 = 0.78 mu M), being the most selective toward this tumoral cell (SI > 20). All compounds described in this work were more active than lawsone, indicating the importance of the carbohydrate and glycosyl triazole moiety for activity.
机译:乳腺癌是女性最多的事件和致命癌症类型,估计在全球2020年预计2000年的新案件,死亡60万人。同样不是所有乳腺癌类型应对抗激素治疗,新的抗肿瘤药物的发展是必要的。授权(2-羟基-1,4-萘酮)是一种天然生物活性萘醌,显示各种活动,其中文​​献中描述了几十个衍生物,包括一些具有抗肿瘤活性的糖苷。在此,首次报告了一系列诉讼授权糖苷,并且所有化合物对Skbr-3细胞系显示出良好的活性,IC50低于10μm。最有前途的衍生物是衍生自过丙基化D-葡萄糖的糖基三唑( 11),其对Skbr-3(IC50 =0.78μm)显示出更好的细胞毒性,是对该肿瘤细胞(Si> 20)最有选择的。本作作品中描述的所有化合物比授权更活跃,表明碳水化合物和糖基三唑部分对活性的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号